PHARMEX AS

0489 OSLO

Finances

Share Ownership

Return on Equity

42,84 %

Current Ratio

3,22

Debt-to-Equity Ratio

0,05

Key figures (NOK)	2022	2021	2020	2019
Revenue	22 673 000	17 151 000	13 442 000	15 894 000
Net Income	2 604 000	1 821 000	1 705 000	3 572 000
Total Assets	9 224 000	9 109 000	8 267 000	7 014 000
Total Equity	6 078 000	4 975 000	5 754 000	5 048 000

Income (NOK)	2022	2021	2020	2019
Revenue	22 673 000	17 151 000	13 442 000	15 894 000
Expenditure	18 064 000	16 171 000	12 763 000	10 814 000
Operating Profit	3 828 000	1 703 000	2 471 000	4 410 000
Financial Income	337 000	729 000	609 000	215 000
Financial Costs	827 000	97 000	893 000	101 000
Financial Balance	−490 000	632 000	−284 000	114 000
Earnings Before Tax	3 338 000	2 335 000	2 187 000	4 524 000
Tax	734 000	514 000	481 000	952 000
Net Income	2 604 000	1 821 000	1 705 000	3 572 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	0	0
Total Current Assets	9 224 000	9 109 000	8 267 000	7 014 000
Total Assets	9 224 000	9 109 000	8 267 000	7 014 000
Total Retained Equity	5 477 000	4 373 000	5 152 000	4 447 000
Total Equity	6 078 000	4 975 000	5 754 000	5 048 000
Total Long-Term Debt	282 000	384 000	530 000	662 000
Total Current Debt	2 864 000	3 751 000	1 983 000	1 304 000
Total Equity and Debt	9 224 000	9 109 000	8 267 000	7 014 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	22 673 000	17 151 000	13 442 000	11 894 000
Other Income	0	0	0	4 000 000
Revenue	22 673 000	17 151 000	13 442 000	15 894 000
Cost of Goods Sold	13 749 000	12 455 000	8 986 000	6 619 000
Salary Costs	2 045 000	1 922 000	1 810 000	1 776 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	18 064 000	16 171 000	12 763 000	10 814 000
Operating Profit	3 828 000	1 703 000	2 471 000	4 410 000
Financial Income	337 000	729 000	609 000	215 000
Financial Costs	827 000	97 000	893 000	101 000
Financial Balance	−490 000	632 000	−284 000	114 000
Dividends	1 500 000	2 600 000	1 000 000	500 000
Net Income	2 604 000	1 821 000	1 705 000	3 572 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	2 257 000	2 984 000	2 274 000	481 000
Total Investments	0	0	0	0
Cash, Bank	3 366 000	3 828 000	4 196 000	4 445 000
Total Current Assets	9 224 000	9 109 000	8 267 000	7 014 000
Total Assets	9 224 000	9 109 000	8 267 000	7 014 000
Total Equity	6 078 000	4 975 000	5 754 000	5 048 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	282 000	384 000	530 000	662 000
Creditors	50 000	0	15 000	21 000
Unpaid Taxes	268 000	288 000	162 000	244 000
Dividends	1 500 000	2 600 000	1 000 000	500 000
Other Current Debt	211 000	1 202 000	193 000	249 000
Total Current Debt	2 864 000	3 751 000	1 983 000	1 304 000
Total Equity and Debt	9 224 000	9 109 000	8 267 000	7 014 000

Financial indicators	2022	2021	2020	2019
Return on Equity	42,84 %	36,6 %	29,63 %	70,76 %
Debt-to-Equity Ratio	0,05	0,08	0,09	0,13
Operating Profit Margin	16,88 %	9,93 %	18,38 %	27,75 %
Current Ratio	3,22	2,43	4,17	5,38
Quick Ratio	15,2	11,88	−28,41	8,52
Equity Ratio	0,66	0,55	0,7	0,72
Gross Profit Margin	39,36 %	27,38 %	33,15 %	58,36 %